Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Boehringer Ingelheim is set to take over Amgen's rights in and substantially all assets at its Fremont Callifornia development and manufacturing facility.
Subscribe to our email newsletter
Amgen‘s 100,000sqft manufacturing facility houses process development labs with pilot plant and currently employs 360 employees.
Amgen has acquired Fremont facility through its 2006 acquisition of Abgenix.
Boehringer Ingelheim board of managing directors Wolfram Carius said the technological expertise at Fremont and the facility will enable them to further strengthen their global Contract Manufacturing Business including new biological entity process development and manufacturing efforts.